Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: May 26, 2009

Premium

Fan Chen has joined genomic diagnostic startup Medomics (see article in this issue) as chief technical officer. Most recently, he was a principal scientist at Focus Diagnostics, which is part of Quest Diagnostics. Prior to that, he was director of R&D at Clingenix, where he focused on diagnostic marker discovery and development. He also held scientific and management positions at MJ Research, Iris Biotechnologies, and Warner Lambert Pharmaceuticals. Chen holds a BS in medicine from Beijing University and a PhD in medical sciences from Nagoya University in Japan.


Antonius Schuh and Michael McNulty have joined the board of directors of Transgenomic.

Schuh is the founding chairman and CEO of Sorrento Therapeutics, a biotechnology company. Prior to that, he was the founding CEO and director of AviaraDx, a molecular diagnostics laboratory company, and before that, he was CEO of Arcturus Bioscience and Sequenom.

McNulty is general manager of diagnostics at Agilent Technologies. Prior to that, he was vice president of laboratory operations and chief compliance officer of Berkeley Heartlabs.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.